Bridgebio Oncology Therapeutics, Inc. (BBOT)
8.80
+0.01
(+0.11%)
USD |
NASDAQ |
Apr 28, 16:00
8.97
+0.17
(+1.93%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Market Cap : 704.29M for April 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| EyePoint, Inc. | 1.124B |
| Praxis Precision Medicines, Inc. | 8.966B |
| Rapport Therapeutics, Inc. | 1.613B |
| Regeneron Pharmaceuticals, Inc. | 77.36B |
| Olema Pharmaceuticals, Inc. | 1.272B |
Market Cap Related Metrics
| Price to Book Value | 1.713 |
| Price | 8.80 |
| Earnings Yield | -17.00% |